• Je něco špatně v tomto záznamu ?

Three-dimensional conformal external beam radiotherapy versus the combination of external radiotherapy with high-dose rate brachytherapy in localized carcinoma of the prostate: comparison of acute toxicity

Soumarová R, Homola L, Perková H, Stursa M

. 2007 ; 93 (1) : 37-44.

Jazyk angličtina Země Itálie

Typ dokumentu klinické zkoušky, srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07527065

AIMS AND BACKGROUND: Radiotherapy represents one of the basic therapeutic methods in treatment of localized carcinoma of the prostate. Optimal irradiation dose is the cornerstone of a successful treatment. Along with local control of the disease and overall survival of the patient, possible acute and long-term side effects need to be monitored very closely. METHODS: A non-randomized prospective study comparing the acute genitourinary and gastrointestinal toxicity in patients irradiated for localized carcinoma of the prostate. Fifty-seven patients were treated with three-dimensional conformal external beam radiotherapy alone, and in the second treatment arm a combination of external beam radiotherapy and high-dose rate brachytherapy was employed in 40 patients. RESULTS: Three-dimensional conformal external beam radiotherapy. Acute G1 genitourinary toxicity was recorded in 35.1% of patients, G2 in 22.8%, and G2-3 in one patient (1.7%). Acute gastrointestinal toxicity was experienced by 54.4% of patients, G1 in 28.1%, G2 in 17.5%, and G3 in 8.8%. Three-dimensional conformal external beam radiotherapy + brachytherapy. Acute G1 genitourinary toxicity was recorded in 37.5% and grade 2 in 15% of the patients. Only G1 acute gastrointestinal toxicity was recorded in 40% of the patients. CONCLUSIONS: Acute G1 genitourinary toxicity was experienced by a similar percentage of patients in both treatment arms. Acute G2 genitourinary toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute genitourinary toxicity, G3 or G4, was recorded only in one patient per treatment arm. Acute gastrointestinal toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute gastrointestinal toxicity, G2 and G3, was only observed in the three-dimensional conformal radiotherapy arm. The acute toxicity observed was of a low grade. The combination of external beam radiotherapy with brachytherapy resulted in a lower incidence of gastrointestinal toxicity than external beam radiotherapy alone.

000      
00000naa 2200000 a 4500
001      
bmc07527065
003      
CZ-PrNML
005      
20111210143539.0
008      
090809s2007 it e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Soumarová, Renata $7 xx0031806
245    10
$a Three-dimensional conformal external beam radiotherapy versus the combination of external radiotherapy with high-dose rate brachytherapy in localized carcinoma of the prostate: comparison of acute toxicity / $c Soumarová R, Homola L, Perková H, Stursa M
314    __
$a JG Mendel Cancer Center Nový Jicín, Hospital Nový Jicín, Czech Republic. renata.soumarova@radioterapie.cz
520    9_
$a AIMS AND BACKGROUND: Radiotherapy represents one of the basic therapeutic methods in treatment of localized carcinoma of the prostate. Optimal irradiation dose is the cornerstone of a successful treatment. Along with local control of the disease and overall survival of the patient, possible acute and long-term side effects need to be monitored very closely. METHODS: A non-randomized prospective study comparing the acute genitourinary and gastrointestinal toxicity in patients irradiated for localized carcinoma of the prostate. Fifty-seven patients were treated with three-dimensional conformal external beam radiotherapy alone, and in the second treatment arm a combination of external beam radiotherapy and high-dose rate brachytherapy was employed in 40 patients. RESULTS: Three-dimensional conformal external beam radiotherapy. Acute G1 genitourinary toxicity was recorded in 35.1% of patients, G2 in 22.8%, and G2-3 in one patient (1.7%). Acute gastrointestinal toxicity was experienced by 54.4% of patients, G1 in 28.1%, G2 in 17.5%, and G3 in 8.8%. Three-dimensional conformal external beam radiotherapy + brachytherapy. Acute G1 genitourinary toxicity was recorded in 37.5% and grade 2 in 15% of the patients. Only G1 acute gastrointestinal toxicity was recorded in 40% of the patients. CONCLUSIONS: Acute G1 genitourinary toxicity was experienced by a similar percentage of patients in both treatment arms. Acute G2 genitourinary toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute genitourinary toxicity, G3 or G4, was recorded only in one patient per treatment arm. Acute gastrointestinal toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute gastrointestinal toxicity, G2 and G3, was only observed in the three-dimensional conformal radiotherapy arm. The acute toxicity observed was of a low grade. The combination of external beam radiotherapy with brachytherapy resulted in a lower incidence of gastrointestinal toxicity than external beam radiotherapy alone.
650    _2
$a adenokarcinom $x radioterapie $7 D000230
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a brachyterapie $x škodlivé účinky $7 D001918
650    _2
$a gastrointestinální trakt $x účinky záření $7 D041981
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory prostaty $x radioterapie $7 D011471
650    _2
$a celková dávka radioterapie $7 D011879
650    _2
$a konformní radioterapie $x škodlivé účinky $7 D020266
650    _2
$a urogenitální systém $x účinky záření $7 D014566
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Homola, Luboš, $d 1965- $7 mzk2007401226
700    1_
$a Perková, Hana $7 xx0135659
700    1_
$a Štursa, Miroslav $7 xx0139432
773    0_
$w MED00010709 $t Tumori $g Roč. 93, č. 1 (2007), s. 37-44 $x 0300-8916
910    __
$a ABA008 $b x $y 7
990    __
$a 20090726182400 $b ABA008
991    __
$a 20090810052914 $b ABA008
999    __
$a ok $b bmc $g 671059 $s 530232
BAS    __
$a 3
BMC    __
$a 2007 $b 93 $c 1 $d 37-44 $i 0300-8916 $m Tumori $x MED00010709
LZP    __
$a 2009-B3/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...